TRESCON
|
TRESCON Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.04 | 0.20 | 0.40 | 0.18 | 0.27 |
| CEPS(Rs) | 0.03 | 0.21 | 0.40 | 0.18 | 0.30 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 15.32 | 15.36 | 15.16 | 14.76 | 14.58 |
| Tax Rate(%) | 296.37 | 43.90 | 15.98 | 22.86 | 42.51 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -54.87 | - | - | -64.56 | -18.13 |
| EBIT Margin(%) | 3.36 | - | - | 137.91 | 101.61 |
| Pre Tax Margin(%) | 1.56 | - | - | 137.25 | 93.43 |
| PAT Margin (%) | -3.07 | - | - | 105.88 | 53.72 |
| Cash Profit Margin (%) | 1.93 | - | - | 107.01 | 59.87 |
| Performance Ratios | |||||
| ROA(%) | -0.24 | 1.29 | 2.62 | 1.19 | 1.84 |
| ROE(%) | -0.26 | 1.31 | 2.66 | 1.22 | 1.98 |
| ROCE(%) | 0.27 | 2.36 | 3.15 | 1.58 | 3.59 |
| Asset Turnover(x) | 0.08 | - | - | 0.01 | 0.03 |
| Sales/Fixed Asset(x) | 1.71 | - | - | 1.03 | 2.36 |
| Working Capital/Sales(x) | 0.10 | - | - | 0.02 | 0.07 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | - | - | 0.97 | 0.42 |
| Receivable days | 56.15 | - | - | 666.46 | 214.51 |
| Inventory Days | 578.07 | - | - | - | - |
| Payable days | -94.32 | -16.75 | - | 300.50 | 105.74 |
| Valuation Parameters | |||||
| PER(x) | - | 73.05 | 20.83 | 101.04 | 211.94 |
| PCE(x) | 408.62 | 69.32 | 20.79 | 99.97 | 190.18 |
| Price/Book(x) | 0.68 | 0.95 | 0.55 | 1.23 | 3.96 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 8.95 | - | - | 106.06 | 113.38 |
| EV/Core EBITDA(x) | 107.00 | 39.31 | 17.38 | 76.28 | 97.01 |
| EV/EBIT(x) | 266.06 | 40.48 | 17.67 | 76.90 | 111.58 |
| EV/CE(x) | 0.69 | 0.95 | 0.55 | 1.20 | 3.78 |
| M Cap / Sales | 7.88 | - | - | 106.98 | 113.85 |
| Growth Ratio | |||||
| Net Sales Growth(%) | - | - | -100.00 | -66.65 | - |
| Core EBITDA Growth(%) | -70.42 | -22.45 | 104.73 | -60.32 | -11.01 |
| EBIT Growth(%) | -87.75 | -23.44 | 103.02 | -54.73 | -14.01 |
| PAT Growth(%) | -120.24 | -49.63 | 122.09 | -34.26 | -39.95 |
| EPS Growth(%) | -120.26 | -49.64 | 122.12 | -34.26 | -45.89 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.12 | - | 0.01 | 0.01 | 0.01 |
| Current Ratio(x) | 5.26 | 53.68 | 65.40 | 75.92 | 14.09 |
| Quick Ratio(x) | 4.25 | 49.25 | 65.40 | 75.92 | 14.09 |
| Interest Cover(x) | 1.87 | 66.15 | 3,047.64 | 209.03 | 12.43 |
| Total Debt/Mcap(x) | 0.17 | - | 0.01 | 0.01 | - |
Compare Financial Ratios of peers of TRESCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRESCON | ₹79.2 Cr | -1.2% | 4.1% | -30% | Stock Analytics | |
| INDRAYANI BIOTECH | ₹72.6 Cr | 12.9% | 28.9% | -65.7% | Stock Analytics | |
TRESCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRESCON | -1.2% |
4.1% |
-30% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses
